{
    "startDate": "2018-01-01",
    "endDate": "2018-12-31",
    "year": "2018",
    "quarter": "FY",
    "symbol": "IONS",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 278820000
            },
            {
                "label": "Short-term investments",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
                "unit": "usd",
                "value": 1805252000
            },
            {
                "label": "Contracts receivable",
                "concept": "ContractWithCustomerAssetNetCurrent",
                "unit": "usd",
                "value": 12759000
            },
            {
                "label": "Inventories",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 8582000
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 102473000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 2207886000
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 132160000
            },
            {
                "label": "Patents, net",
                "concept": "FiniteLivedIntangibleAssetsNet",
                "unit": "usd",
                "value": 24032000
            },
            {
                "label": "Long-term deferred tax assets",
                "concept": "DeferredTaxAssetsLiabilitiesNetNoncurrent",
                "unit": "usd",
                "value": 290796000
            },
            {
                "label": "Deposits and other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 12910000
            },
            {
                "label": "Amortization of patents",
                "concept": "Assets",
                "unit": "usd",
                "value": 2667784000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 28660000
            },
            {
                "label": "Accrued compensation",
                "concept": "EmployeeRelatedLiabilitiesCurrent",
                "unit": "usd",
                "value": 29268000
            },
            {
                "label": "Accrued liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 48361000
            },
            {
                "label": "Current portion of deferred contract revenue",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 160256000
            },
            {
                "label": "Accrued liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 280294000
            },
            {
                "label": "Long-term deferred contract revenue",
                "concept": "ContractWithCustomerLiabilityNoncurrent",
                "unit": "usd",
                "value": 567359000
            },
            {
                "label": "1 percent convertible senior notes",
                "concept": "ConvertibleDebtNoncurrent",
                "unit": "usd",
                "value": 568215000
            },
            {
                "label": "Long-term mortgage debt",
                "concept": "LongTermLoansFromBank",
                "unit": "usd",
                "value": 59842000
            },
            {
                "label": "Accrued liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 1480624000
            },
            {
                "label": "Common stock, $0.001 par value; 300,000,000 shares authorized, 137,928,828 and 124,976,373 shares issued and outstanding at December 31, 2018 and December 31, 2017, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 138000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 2047250000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -32016000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -967293000
            },
            {
                "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 1048079000
            },
            {
                "label": "Loss before income tax benefit (expense)",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 139081000
            },
            {
                "label": "Total stockholders' equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 1187160000
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS' EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 2667784000
            }
        ],
        "cf": [
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 214985000
            },
            {
                "label": "Less accumulated depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 10706000
            },
            {
                "label": "Amortization of patents",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 1822000
            },
            {
                "label": "Amortization of premium (discount) on investments, net",
                "concept": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
                "unit": "usd",
                "value": 1013000
            },
            {
                "label": "Amortization of debt discount and debt issuance costs",
                "concept": "AmortizationOfFinancingCosts",
                "unit": "usd",
                "value": 1810000
            },
            {
                "label": "Amortization of convertible senior notes discount",
                "concept": "AmortizationOfDebtDiscountPremium",
                "unit": "usd",
                "value": 33363000
            },
            {
                "label": "Amortization of long-term financing liability for leased facility",
                "concept": "AmortizationOfLeasedAsset",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Excess tax benefits from stock-based compensation awards",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 131312000
            },
            {
                "label": "Gain on investment in Regulus Therapeutics, Inc.",
                "concept": "GainOnSaleOfInvestments",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Loss on early retirement of debt",
                "concept": "GainsLossesOnExtinguishmentOfDebt",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Deferred income taxes (including benefit from valuation allowance release)",
                "concept": "DeferredIncomeTaxesAndTaxCredits",
                "unit": "usd",
                "value": -290516000
            },
            {
                "label": "Contracts receivable",
                "concept": "IncreaseDecreaseInContractWithCustomerAsset",
                "unit": "usd",
                "value": -47595000
            },
            {
                "label": "Inventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": -1400000
            },
            {
                "label": "Other current and long-term assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": 29348000
            },
            {
                "label": "Long-term income tax receivable",
                "concept": "IncreaseDecreaseInIncomeTaxesReceivable",
                "unit": "usd",
                "value": 223000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -655000
            },
            {
                "label": "Income taxes",
                "concept": "IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable",
                "unit": "usd",
                "value": -710000
            },
            {
                "label": "Accrued compensation",
                "concept": "IncreaseDecreaseInOtherEmployeeRelatedLiabilities",
                "unit": "usd",
                "value": 4117000
            },
            {
                "label": "Deferred contract revenue",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": 494254000
            },
            {
                "label": "Operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 602888000
            },
            {
                "label": "Purchases of short-term investments",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 1794735000
            },
            {
                "label": "Proceeds from the sale of short-term investments",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 882824000
            },
            {
                "label": "Purchases of property, plant and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 13608000
            },
            {
                "label": "Proceeds from the sale of Regulus Therapeutics, Inc.",
                "concept": "ProceedsFromSaleOfEquityMethodInvestments",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Net cash (used in) provided by investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -929563000
            },
            {
                "label": "Net proceeds from stock option exercises, vesting of restricted stock units, and ESPP purchases",
                "concept": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
                "unit": "usd",
                "value": 27900000
            },
            {
                "label": "Proceeds from issuance of common stock in Akcea Therapeutics, Inc. from its initial public offering, net of underwriters' discount",
                "concept": "ProceedsFromIssuanceInitialPublicOffering",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Proceeds from building mortgage debt, net of issuance costs",
                "concept": "ProceedsFromDebtNetOfIssuanceCosts",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Proceeds from borrowing on line of credit facility",
                "concept": "ProceedsFromLinesOfCredit",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Proceeds from the sale of Akcea Therapeutics, Inc. common stock to Novartis in a private placement",
                "concept": "ProceedsFromIssuanceOfPrivatePlacement",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Offering costs paid",
                "concept": "PaymentsOfStockIssuanceCosts",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Excess tax benefits from stock-based compensation awards",
                "concept": "ExcessTaxBenefitFromShareBasedCompensationFinancingActivities",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Principal payments on debt and capital lease obligations",
                "concept": "RepaymentsOfLongTermDebtAndCapitalSecurities",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 475865000
            },
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 149190000
            },
            {
                "label": "Interest paid",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 9592000
            },
            {
                "label": "Purchases of property, plant and equipment included in long-term obligations",
                "concept": "CapitalExpendituresIncurredButNotYetPaid",
                "unit": "usd",
                "value": 3350000
            },
            {
                "label": "1 percent convertible senior notes principal issued related to our December 2016 debt exchange",
                "concept": "NotesIssued1",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "2 3/4 percent convertible senior notes principal extinguished related to our December 2016 debt exchange",
                "concept": "NotesReduction",
                "unit": "usd",
                "value": 0
            }
        ],
        "ic": [
            {
                "label": "Revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 599674000
            },
            {
                "label": "Cost of Products Sold [Abstract]",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 1820000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 244622000
            },
            {
                "label": "Expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 661046000
            },
            {
                "label": "Income (loss) from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -61372000
            },
            {
                "label": "Investment income",
                "concept": "InvestmentIncomeNet",
                "unit": "usd",
                "value": 30187000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 44789000
            },
            {
                "label": "Loss on early retirement of debt",
                "concept": "GainsLossesOnExtinguishmentOfDebt",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Other expenses",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -182000
            },
            {
                "label": "Loss before income tax benefit (expense)",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -76156000
            },
            {
                "label": "Total current income tax (benefit) expense",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": -291141000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 214985000
            },
            {
                "label": "Net loss attributable to noncontrolling interest in Akcea Therapeutics, Inc.",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -58756000
            },
            {
                "label": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 273741000
            },
            {
                "label": "Basic net income (loss) per share (in dollars per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 2.09
            },
            {
                "label": "Shares used in computing basic net income (loss) per share (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 132320000
            },
            {
                "label": "Diluted net income (loss) per share (in dollars per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": 2.07
            },
            {
                "label": "Shares used in computing diluted net income (loss) per share (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 134056000
            },
            {
                "label": "Unrealized losses on investments, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -280000
            },
            {
                "label": "Reclassification adjustment for realized (gains) losses included in net loss",
                "concept": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Currency translation adjustment",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 23000
            },
            {
                "label": "Comprehensive income (loss)",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 214728000
            },
            {
                "label": "Noncontrolling interest in Akcea Therapetuics, Inc.",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -58781000
            },
            {
                "label": "Noncontrolling interest in Akcea Therapetuics, Inc.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 273509000
            }
        ]
    }
}